Literature DB >> 18534624

Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies.

Kazuyuki Ishida1, Hiroshi Mitoma, Hidehiro Mizusawa.   

Abstract

Anti-glutamic acid decarboxylase autoantibodies (GAD-Abs) are found in some patients with cerebellar ataxia. We reported previously that CSF IgGs depress cerebellar GABAergic synaptic transmissions by a presynaptic mechanism. Using whole-cell recordings from rat cerebellar slices, we found in the present study that CSF IgG-induced depressive effects were abolished by absorption of GAD-Abs using recombinant GAD. Furthermore, forskolin, an activator of cAMP, recovered the CSF IgG-induced reduction of GABA release. Our results provide evidence that GAD-Abs in the CSF elicited physiopathological effects on cerebellar GABA synapses in vitro and that such synaptic impairment was reversible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534624     DOI: 10.1016/j.jns.2008.04.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

Review 1.  Autoimmune encephalitis update.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Neuro Oncol       Date:  2014-03-16       Impact factor: 12.300

Review 2.  Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.

Authors:  Eric Lancaster; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

3.  Presence of GAD65 autoantibodies in the serum of children with autism or ADHD.

Authors:  Ujjwal K Rout; Nils K Mungan; Dirk M Dhossche
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-10       Impact factor: 4.785

4.  Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Authors:  Helena Ariño; Nuria Gresa-Arribas; Yolanda Blanco; Eugenia Martínez-Hernández; Lidia Sabater; Mar Petit-Pedrol; Idoia Rouco; Luis Bataller; Josep O Dalmau; Albert Saiz; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

Review 5.  Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies.

Authors:  Hiroshi Mitoma; Mario Manto
Journal:  Cerebellum       Date:  2022-01-22       Impact factor: 3.847

Review 6.  Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Keya Adhikari; Daniel Aeschlimann; Partha Chattopadhyay; Marios Hadjivassiliou; Christiane S Hampe; Jérôme Honnorat; Bastien Joubert; Shinji Kakei; Jongho Lee; Mario Manto; Akiko Matsunaga; Hidehiro Mizusawa; Kazunori Nanri; Priya Shanmugarajah; Makoto Yoneda; Nobuhiro Yuki
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

7.  Serum from a Patient with GAD65 Antibody-Associated Limbic Encephalitis Did Not Alter GABAergic Neurotransmission in Cultured Hippocampal Networks.

Authors:  Nelly Stemmler; Karin Rohleder; Michael P Malter; Guido Widman; Christian E Elger; Heinz Beck; Rainer Surges
Journal:  Front Neurol       Date:  2015-08-28       Impact factor: 4.003

8.  Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions.

Authors:  Mario Manto; Jérôme Honnorat; Christiane S Hampe; Rafael Guerra-Narbona; Juan Carlos López-Ramos; José María Delgado-García; Fumihito Saitow; Hidenori Suzuki; Yuchio Yanagawa; Hidehiro Mizusawa; Hiroshi Mitoma
Journal:  Front Behav Neurosci       Date:  2015-03-27       Impact factor: 3.558

9.  Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.

Authors:  Yoshitsugu Nakamura; Hideto Nakajima; Takafumi Hosokawa; Kazushi Yamane; Shimon Ishida; Fumiharu Kimura
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

10.  Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.

Authors:  Christiane S Hampe; Laura Petrosini; Paola De Bartolo; Paola Caporali; Debora Cutuli; Daniela Laricchiuta; Francesca Foti; Jared R Radtke; Veronika Vidova; Jérôme Honnorat; Mario Manto
Journal:  Orphanet J Rare Dis       Date:  2013-06-05       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.